Anisotropic Cryostructured Collagen Scaffolds for Efficient Delivery of RhBMP–2 and Enhanced Bone Regeneration
Authors:
- Kai StuckensenKSKai Stuckensen
- José M. Lamo-EspinosaJLJosé M. Lamo-Espinosa
- Emma Muiños-LópezEMEmma Muiños-López
- Purificación Ripalda-CemboráinPRPurificación Ripalda-Cemboráin
- Tania López-MartínezTLTania López-Martínez
- Elena IglesiasEIElena Iglesias
- Gloria AbizandaGAGloria Abizanda
- Ion AndreuIAIon Andreu
- María Flandes-IparraguirreMFMaría Flandes-Iparraguirre
- Juan Pons-VillanuevaJPJuan Pons-Villanueva
- Reyes ElizaldeREReyes Elizalde
- Joachim NickelJNJoachim Nickel
Open Access
- 24 September 2019
- Vol. 12 (19) , 3105
Abstract
In the treatment of bone non-unions, an alternative to bone autografts is the use of bone morphogenetic proteins (BMPs), e.g., BMP–2, BMP–7, with powerful osteoinductive and osteogenic properties. In clinical settings, these osteogenic factors are applied using absorbable collagen sponges for local controlled delivery. Major side effects of this strategy are derived from the supraphysiological doses of BMPs needed, which may induce ectopic bone formation, chronic inflammation, and excessive bone resorption. In order to increase the efficiency of the delivered BMPs, we designed cryostructured collagen scaffolds functionalized with hydroxyapatite, mimicking the structure of cortical bone (aligned porosity, anisotropic) or trabecular bone (random distributed porosity, isotropic). We hypothesize that an anisotropic structure would enhance the osteoconductive properties of the scaffolds by increasing the regenerative performance of the provided rhBMP–2. In vitro, both scaffolds presented similar mechanical properties, rhBMP–2 retention and delivery capacity, as well as scaffold degradation time. In vivo, anisotropic scaffolds demonstrated better bone regeneration capabilities in a rat femoral critical-size defect model by increasing the defect bridging. In conclusion, anisotropic cryostructured collagen scaffolds improve bone regeneration by increasing the efficiency of rhBMP–2 mediated bone healing.Keywords
Funding Information
- Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (PI17/00136, RD12/0019/0031, RD16/0011/0005)
- Seventh Framework Programme (309962, HydroZONES)
This publication has 33 references indexed in Scilit:
- Effects of protein dose and delivery system on BMP-mediated bone regenerationBiomaterials, 2011
- Bone regeneration: current concepts and future directionsBMC Medicine, 2011
- High Doses of Bone Morphogenetic Protein 2 Induce Structurally Abnormal Bone and Inflammation In VivoTissue Engineering Part A, 2011
- Dose Effect of Dual Delivery of Vascular Endothelial Growth Factor and Bone Morphogenetic Protein-2 on Bone Regeneration in a Rat Critical-Size Defect ModelTissue Engineering Part A, 2009
- Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect modelBone, 2008
- Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery)Journal of Tissue Engineering and Regenerative Medicine, 2008
- Differences between the effect of anisotropic and isotropic laminin and nerve growth factor presenting scaffolds on nerve regeneration across long peripheral nerve gapsBiomaterials, 2008
- OP-1/BMP-7 in cartilage repairInternational Orthopaedics, 2007
- Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgeryInternational Orthopaedics, 2007
- Tendon and ligament engineering in the adult organism: mesenchymal stem cells and gene-therapeutic approachesInternational Orthopaedics, 2007